Sponsored Links
| NanoViricides Presents FluCide™ Animal Study Data At Influenza Congress - Now Improved Substantially And Vastly Superior To Current Treatment |
 |
 |
 |
| Medical News - Flu Cold SARS | |||
|
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced that Dr. Eugene Seymour, MD MPH, CEO of the Company, presented lifetime data from the recent FluCide™ animal study on November 19th at the Influenza Congress USA 2009 in Washington, DC (http://www.terrapinn.com/usaflu). These data clearly established that the new version of FluCide™ is superior to the older version... Read more: Flu / Cold / SARS News From Medical News Today
|